FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
LIALDA
mesalamine
LOE Approaching
Takeda
ORAL · TABLET, DELAYED RELEASE
ulcerative colitis
2007
NDA30/100
LIBRAX
chlordiazepoxide hydrochloride and clidinium bromide
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE
1966
NDA30/100
LIBRELEASE
chlordiazepoxide
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE, EXTENDED RELEASE
1983
NDA30/100
LIBRIUM
chlordiazepoxide hydrochloride
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE
1960
NDA30/100
LIBRIUM
chlordiazepoxide hydrochloride
LOE Approaching
Bausch + Lomb
INJECTION · INJECTABLE
1961
NDA30/100
LIDEX
fluocinonide
LOE Approaching
Alvogen
TOPICAL · SOLUTION
1984
NDA30/100
LIDEX
fluocinonide
LOE Approaching
Alvogen
TOPICAL · CREAM
1971
NDA30/100
LIDEX
fluocinonide
LOE Approaching
Alvogen
TOPICAL · OINTMENT
1971
NDA30/100
LIDEX-E
fluocinonide
LOE Approaching
Alvogen
TOPICAL · CREAM
1971
NDA30/100
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
LOE Approaching
Bristol Myers Squibb
INJECTION · INJECTABLE
1976
NDA30/100
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
LOE Approaching
Medica Corp
INJECTION · INJECTABLE
1976
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
the acute management of (1) ventricular arrhythmias occurring during cardiac manipulationssuch
1981
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1984
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride anhydrous and dextrose monohydrate
LOE Approaching
B. Braun
INJECTION · INJECTABLE
the acute management of (1) ventricular arrhythmias occurring during cardiac manipulationssuch
1992
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
the acute management of (1) ventricular arrhythmias occurring during cardiac manipulationssuch
1981
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
Abbott
INJECTION · INJECTABLE
1985
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1980
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride anhydrous and dextrose monohydrate
LOE Approaching
B. Braun
INJECTION · INJECTABLE
the acute management of (1) ventricular arrhythmias occurring during cardiac manipulationssuch
1992
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
the acute management of (1) ventricular arrhythmias occurring during cardiac manipulationssuch
1981
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1984
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1980
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride anhydrous and dextrose monohydrate
LOE Approaching
B. Braun
INJECTION · INJECTABLE
the acute management of (1) ventricular arrhythmias occurring during cardiac manipulationssuch
1992
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1984
NDA30/100
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
the acute management of (1) ventricular arrhythmias occurring during cardiac manipulationssuch
1981
NDA30/100